**1. Apotex Inc. (TSX: APO)** Apotex Inc. is a leading Canadian pharmaceutical company known for its strong presence in generic drug manufacturing. In 2024, Apotex has emerged as one of the best-performing pharma stocks in Canada due to its strategic expansion into international markets and a robust product pipeline. The company has shown impressive growth by consistently introducing new generic versions of popular drugs and expanding its reach in both developed and emerging markets. Apotex's focus on innovation, cost-effectiveness, and operational efficiency has contributed significantly to its success in 2024. Investors have taken notice of the company's strong performance, leading to a steady increase in stock value throughout the year. **2. Bausch Health Companies Inc. (TSX: BHC)** Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, has made a remarkable comeback in 2024, positioning itself as one of the top-performing pharma stocks in Canada. The company's transformation strategy, including debt reduction and portfolio optimization, has resonated well with investors, resulting in a surge in stock performance. Bausch Health's diversified product portfolio, which includes both branded and generic pharmaceuticals, as well as medical devices, has been a key driver of its success in 2024. The company's focus on research and development, strategic partnerships, and expansion into new markets has further fueled its growth and solidified its position as a top-performing Canadian pharmaceutical stock. **3. Knight Therapeutics Inc. (TSX: GUD)** Knight Therapeutics Inc. is a specialty pharmaceutical company that has shown remarkable performance in 2024, making it one of the best-performing pharma stocks in Canada. The company's strategic focus on acquiring and commercializing innovative pharmaceutical products has paid off, with a steady increase in revenue and stock value over the year. Knight Therapeutics' business model, which prioritizes agility, flexibility, and quick decision-making, has enabled the company to capitalize on emerging opportunities and adapt to changing market dynamics. In addition, the company's strong leadership team and commitment to product quality and patient outcomes have garnered investor confidence and contributed to its success in 2024. In conclusion, Apotex Inc., Bausch Health Companies Inc., and Knight Therapeutics Inc. have emerged as the top-performing Canadian pharmaceutical stocks in 2024, each showcasing unique strengths and strategies that have propelled their success. Investors looking to capitalize on the growth potential of the Canadian pharma sector may find these stocks particularly appealing due to their strong performance and promising outlook for the future.